Navigation Links
Taming microbes to combat antibiotic resistance
Date:2/25/2014

LOS ANGELES (Feb. 25, 2014) With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them.

Michael Yeaman, PhD, an LA BioMed researcher, recently received an Innovation Award for $1.6 million from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) to develop novel anti-infectives designed to disarm methicillin-resistant S. aureus (MRSA) and reduce its resistance to antibiotics.

"Real-time adaptations in microbes that drive antibiotic treatment failures are known but have been poorly understood," Dr. Yeaman said. "Our approach interferes with the adaptations MRSA uses to survive in the body. Enhancing the effectiveness of existing antibiotics and minimizing resistance by dangerous microbes like MRSA are public health priorities directly addressed by our research."

Dangerous microbes that have survived traditional antibiotics now threaten to cause untreatable infections.

"Antibiotic resistance is a predictable result of microbial survival instincts in the face of drugs that are designed to kill them," Dr. Yeaman said. "New variations on old antibiotics may work in the short term, but inevitably microbes, such as MRSA, adapt to resist even the newest forms of conventional drugs. By fundamentally changing our approach, we are exploring totally new ways to tame the microbes and slow their resistance."

The U.S. Centers for Disease Control and Prevention (CDC) estimate that more than 2 million Americans suffer from antibiotic resistant infections per year. More than 20,000 die from drug-resistant infections annually, and countless more undergo costly and prolonged hospital stays and exposure to ineffective antibiotics. Ironically, these conditions promote further drug resistance. Estimated costs of drug-resistant infections to the healthcare system range as high as $20 billion per year in the U.S. alone with up to $35 billion in additional costs to society for lost productivity, according to the CDC.

This innovative research program includes LA BioMed researchers, Arnold Bayer, MD, and Yan Q. Xiong, MD, PhD. It builds on discoveries already patented by members of the team, and it leverages strategic anti-inflammatory drugs already approved by the Food and Drug Administration.

"Ultimately, results from this program may accelerate pre-clinical and clinical studies of new anti-infective combinations to improve treatment outcomes in life-threatening MRSA and other infections," Dr. Yeaman said. "Our program may also be able to avoid the prohibitive time and cost typical for discovery and development of new drugs and bring novel anti-infectives to market more quickly to address the significant and growing public health threat of antibiotic-resistant infections."


'/>"/>

Contact: Laura Mecoy
lmecoy@labiomed.org
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Related medicine news :

1. Taming physical forces that block cancer treatment
2. Scientists Probe Diversity of Human Bodys Microbes
3. Gut Microbes Might Reflect Health, Diet of Older Adults
4. Weapon-wielding marine microbes may protect populations from foes
5. University of Tennessee study: Unexpected microbes fighting harmful greenhouse gas
6. New biochip technology uses tiny whirlpools to corral microbes
7. Through New Innovative Measures, Highly Pathogenic Microbes Will Now Be Tested Clinically, Strengthening The Front Line In The Fight Against Food-Borne Illness
8. New Technology Automatically Sterilizes Dangerous Microbes at Point of Sale Terminals
9. Gut microbes may be a risk factor for colorectal cancer
10. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
11. For Combat Vets, Brain Injury Symptoms Can Last Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology: